Infectious Diseases Pharmacy Specialist, Immunocompromised

Society of Infectious Diseases Pharmacists (SIDP); Cleveland (OH); On-site; USD 140,000 - 180,000; Full time

Job summary

UH Cleveland Medical Center in Cleveland, OH is seeking a Clinical Pharmacy Specialist in Infectious Diseases to support immunocompromised patients, including those with hematologic malignancies, bone marrow transplant, and solid organ transplant.

The role centers on ID pharmacotherapy, antimicrobial stewardship, and collaboration with physicians, oncology and transplant teams to optimize antimicrobial therapy and improve patient outcomes.

Responsibilities

• Serve as the infectious diseases pharmacotherapy expert for immunocompromised patients, including malignant hematology, bone marrow transplant, cellular therapy, and solid organ transplant patients.
• Participate in inpatient Infectious Diseases consult services caring for immunocompromised patients.
• Conduct prospective antimicrobial stewardship reviews focused on broad-spectrum antibacterial, antiviral, and antifungal therapies.
• Optimize antimicrobial selection, dosing, monitoring, and duration of therapy for complex infectious disease states.
• Collaborate with Infectious Diseases physicians and multidisciplinary care teams to develop individualized treatment plans.
• Lead antimicrobial stewardship and quality improvement initiatives targeting immunocompromised patients.
• Participate in transitions of care and outpatient antimicrobial management initiatives, including backup support for the UH Cleveland Medical Center OPAT Program.
• Support clinical teaching, research, and scholarly activities within the Department of Pharmacy.

Job description

UH Cleveland Medical Center in Cleveland, OH is seeking a Clinical Pharmacy Specialist in Infectious Diseases to support immunocompromised patients, including those with hematologic malignancies, bone marrow transplant, and solid organ transplant.

The role centers on ID pharmacotherapy, antimicrobial stewardship, and collaboration with physicians, oncology and transplant teams to optimize antimicrobial therapy and improve patient outcomes.